Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (411-420 of 790) with videos related to

Pageof 79
Sort By:
Psychiatry Research|March 1, 2015
Progress in mind: focus on alcohol use disorders, an elsevier resource centreD J Nutt, J Rehm, W van den Brink, et al.
Science & Justice : Journal of the Forensic Science Society|July 9, 2014
Scopolamine: useful medicine or dangerous drug?L A King, R Fortson Q C, I Ujváry, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Neuropharmacology|December 31, 2017
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depressionLeor Roseman, Lysia Demetriou, Matthew B Wall, et al.
Neuropharmacology|August 26, 2018
Psychedelics - Re-opening the doors of perceptionDavid J Heal, Jack Henningfield, Bruno G Frenguelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Harms associated with psychoactive substances: findings of the UK National Drug SurveyCelia J A Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic reviewBerta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled studyY M Hart, H Meinardi, J W Sander, et al.
British Journal of Pharmacology|October 12, 1999
Autoradiographical and behavioural effects of a chronic infusion of antisense to the alpha2D-adrenoceptor in the ratE S Robinson, D J Nutt, L Hall, et al.
Pageof 79

Showing results (411-420 of 790) with videos related to

Sort By:
Pageof 79
Psychiatry Research|March 1, 2015
Progress in mind: focus on alcohol use disorders, an elsevier resource centreD J Nutt, J Rehm, W van den Brink, et al.
Science & Justice : Journal of the Forensic Science Society|July 9, 2014
Scopolamine: useful medicine or dangerous drug?L A King, R Fortson Q C, I Ujváry, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Neuropharmacology|December 31, 2017
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depressionLeor Roseman, Lysia Demetriou, Matthew B Wall, et al.
Neuropharmacology|August 26, 2018
Psychedelics - Re-opening the doors of perceptionDavid J Heal, Jack Henningfield, Bruno G Frenguelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Harms associated with psychoactive substances: findings of the UK National Drug SurveyCelia J A Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic reviewBerta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled studyY M Hart, H Meinardi, J W Sander, et al.
British Journal of Pharmacology|October 12, 1999
Autoradiographical and behavioural effects of a chronic infusion of antisense to the alpha2D-adrenoceptor in the ratE S Robinson, D J Nutt, L Hall, et al.
Pageof 79